Open Search
Close Search
Whistleblower

Policy Implications of Pharmaceutical Importation for U.S. Consumers

Full Committee Hearing
Date:  Wednesday, March 7, 2007
Time:  9:30 AM
Location:  SR

Committee Members

  1. Byron L. Dorgan

    Senator

Testimony

  1. Randall Lutter

    Acting Deputy Commissioner for Policy
    Food and Drug Administration

Witness Panel 2

  1. Nelda Barnett

    Member, Board of Directors
    AARP
    Download Testimony

  2. William Schultz

    Partner
    Zuckerman Spaeder LLP

  3. Stephen Schondelmeyer

    Professor and Head, Department of Pharmaceutical Care & Health Systems
    University of Minnesota, College of Pharmacy

  4. John Vernon

    Assistant Professor, Department of Finance
    University of Connecticut School of Business

  5. Billy Tauzin

    CEO
    PhRMA
    Download Testimony
Print 
Email 
Share 
Share